Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study

Hillel Yaffe Medical Center

Status: Unknown

Conditions: Ovarian Cancer

Treatments: Other: Immunohistochemistry staining method

Study type: Observational

Funder types: Other

Identifiers

NCT02719041

HYMC-19-16

Details and patient eligibility

About

The main goal of this study is to employ a novel proteomic approach to identify predictive tumor biomarkers that will increase the efficacy of insulin-like growth factor (IGF1R) targeted therapy in epithelial ovarian cancer. It is expected that these predictive biomarkers will be applied to increase the response rate in selected groups of patients.

Enrollment: 40 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women who underwent surgery for ovarian cancer

Exclusion criteria

• None

Trial design

40 participants in 1 patient group

Tissue samples

Description:

Tissue samples taken from women treated for ovarian cancer will be stained.

Treatment:

Other: Immunohistochemistry staining method